# Evaluation of the Integrated Radio Frequency Denervation System for the Treatment of Hypertension

> **NCT04740723** · NA · COMPLETED · sponsor: **Metavention** · enrollment: 30 (actual)

## Conditions studied

- Hypertension
- Metabolic Syndrome

## Interventions

- **DEVICE:** iRF System Renal Denervation

## Key facts

- **NCT ID:** NCT04740723
- **Lead sponsor:** Metavention
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-06
- **Primary completion:** 2021-10-20
- **Final completion:** 2022-10-13
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04740723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04740723, "Evaluation of the Integrated Radio Frequency Denervation System for the Treatment of Hypertension". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04740723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*